Navigation Links
Shimadzu's New DSC-60 Plus Series Differential Scanning Calorimeters Offer High-Sensitivity Analysis in Polymer, Food and Pharmaceutical Applications
Date:4/18/2013

Columbia, Maryland (PRWEB) April 18, 2013

Shimadzu Scientific Instruments has introduced the DSC-60 Plus Series differential scanning calorimeters, indispensable thermal analyzers for materials characterization. The DSC-60 Plus Series offers the high-sensitivity analysis and easy operation required for the development of high-functioning new materials in the food, polymer and pharmaceutical industries.

As high-performance, general-purpose differential scanning calorimeters, the DSC-60 Plus Series offers high sensitivity and high resolution during analysis. Its new detector and unique furnace construction achieve a stable baseline across the entire measured temperature range (-140 to 600° C), as well as top-class temperature sensitivity. The eco-friendly furnace achieves more than 20 percent lower energy consumption when heating from room temperature.

A cooling chamber comes installed as standard on the DSC-60 Plus Series. The liquid-nitrogen cooling chamber permits easy measurements without the need for special accessories. Further, it achieves a cooling rate of 10° C/minute at -100° C. Its sample loading temperature function enables quick sample change without dewfall during sequential analysis.

The DSC-60A Plus model features a built-in compact autosampler, which permits automated measurement, analysis and report printout for up to 24 loaded samples. It improves the efficiency of screening during product development, as well as the efficiency of quality control activities.

Additionally, the DSC-60 Plus Series complies with various analytical laboratory regulations, including the U.S. Food and Drug Administration’s 21 CFR Part 11.

For more information about the DSC-60 Plus Series, visit http://www.ssi.shimadzu.com/products/product.cfm?product=dsc60Plus.

About Shimadzu Scientific Instruments Inc.
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit http://www.ssi.shimadzu.com for more information.

###

Read the full story at http://www.prweb.com/releases/2013/4/prweb10650226.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
2. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
3. InnoPharma Completes $15 Million Series A Financing
4. Aratana Therapeutics Completes $15 Million Series B Financing
5. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
6. Roka Bioscience Secures $47.5 Million in Series D Financing
7. Auxogyn Completes $20 Million In Series A Funding
8. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
9. NeuroPhage Extends Series B to $21.4M
10. Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... Hill, CT (PRWEB) , ... June 20, 2017 ... ... support, today announced that the CTNext board of directors has formed a Higher ... by a working group composed of institution presidents and other high-ranking representatives from ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., ... to announce the issuance of a new patent covering ... hyperuricemia by the U.S. Patent and Trademark Office on ... winner of the Buzz of Bio award in 2014 ... akin to developing non-drug approaches to chronic disease. Renadyl™, ...
(Date:6/20/2017)... ... June 20, 2017 , ... GigaGen Inc ., ... immune repertoires, announces launch of its new Surge(TM) Discovery service at ... of GigaGen, will present on Surge at the conference. , Surge is the ...
(Date:6/19/2017)... ... June 19, 2017 , ... Tunnell Consulting has been ... One of the biggest challenges faced by life sciences, biotech and pharmaceuticals companies today ... is Kati Abraham , who is well known in the industry and brings ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
Breaking Biology News(10 mins):